Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Blood to brain to the rescue
Richard L. Proia, Yun-Ping Wu
Richard L. Proia, Yun-Ping Wu
Published April 15, 2004
Citation Information: J Clin Invest. 2004;113(8):1108-1110. https://doi.org/10.1172/JCI21476.
View: Text | PDF
Commentary

Blood to brain to the rescue

  • Text
  • PDF
Abstract

Neurodegeneration occurs in the majority of the more than 40 known lysosomal storage diseases. Since the nervous system in these disorders can be globally affected, effective treatment would require persistent widespread correction. Biffi et al. show such correction is possible in a mouse model of metachromatic leukodystrophy by the transplantation of hematopoietic cells genetically modified to overexpress the missing lysosomal enzyme. The results reveal a nervous system damage-response pathway that can be harnessed to provide therapy to the nervous system in these serious disorders.

Authors

Richard L. Proia, Yun-Ping Wu

×

Total citations by year

Year: 2025 2022 2021 2020 2019 2017 2015 2014 2012 2010 2009 2007 2006 Total
Citations: 1 1 1 1 3 1 1 1 1 2 1 1 1 16
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (16)

Title and authors Publication Year
Defective anterograde protein-trafficking contributes to endoplasmic reticulum-stress in a CLN1 disease model
Plavelil N, Appu AP, KC G, Mondal A, Perkins N, Mukherjee AB
Neurobiology of disease 2025
Ppt1-deficiency dysregulates lysosomal Ca(++) homeostasis contributing to pathogenesis in a mouse model of CLN1 disease.
Mondal A, Appu AP, Sadhukhan T, Bagh MB, Previde RM, Sadhukhan S, Stojilkovic S, Liu A, Mukherjee AB
Journal of Inherited Metabolic Disease 2022
Downregulation of ATP6V1A Involved in Alzheimer’s Disease via Synaptic Vesicle Cycle, Phagosome, and Oxidative Phosphorylation
Z Zhou, J Bai, S Zhong, R Zhang, K Kang, X Zhang, Y Xu, C Zhao, M Zhao, D Vergara
Oxidative Medicine & Cellular Longevity 2021
Cln1-mutations suppress Rab7-RILP interaction and impair autophagy contributing to neuropathology in a mouse model of infantile neuronal ceroid lipofuscinosis.
Sarkar C, Sadhukhan T, Bagh MB, Appu AP, Chandra G, Mondal A, Saha A, Mukherjee AB
Journal of Inherited Metabolic Disease 2020
Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses
AB Mukherjee, AP Appu, T Sadhukhan, S Casey, A Mondal, Z Zhang, MB Bagh
Molecular Neurodegeneration 2019
Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
Appu AP, Bagh MB, Sadhukhan T, Mondal A, Casey S, Mukherjee AB
Journal of Inherited Metabolic Disease 2019
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases.
Faverio P, Stainer A, De Giacomi F, Gasperini S, Motta S, Canonico F, Pieruzzi F, Monzani A, Pesci A, Biondi A
International journal of molecular sciences 2019
Misrouting of v-ATPase subunit V0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model
MB Bagh, S Peng, G Chandra, Z Zhang, SP Singh, N Pattabiraman, A Liu, AB Mukherjee
Nature Communications 2017
Cln1 gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders.
Chandra G, Bagh MB, Peng S, Saha A, Sarkar C, Moralle M, Zhang Z, Mukherjee AB
Human Molecular Genetics 2015
The role of microglia in human disease: therapeutic tool or target?
N Cartier, CA Lewis, R Zhang, FM Rossi
Acta Neuropathologica 2014
Evaluation of neurodegeneration in a mouse model of infantile batten disease by magnetic resonance imaging and magnetic resonance spectroscopy.
Munasinghe J, Zhang Z, Kong E, Heffer A, Mukherjee AB
Neurodegenerative Diseases 2012
Pathophysiology of neuropathic lysosomal storage disorders
CM Bellettato, M Scarpa
Journal of Inherited Metabolic Disease 2010
Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol
H Wei, Z Zhang, A Saha, S Peng, G Chandra, Z Quezado, AB Mukherjee
Human Molecular Genetics 2010
Neural stem cell transplantation benefits a monogenic neurometabolic disorder during the symptomatic phase of disease
M Jeyakumar, JP Lee, NR Sibson, JP Lowe, DJ Stuckey, K Tester, G Fu, R Newlin, DA Smith, EY Snyder, FM Platt
Stem Cells 2009
Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse.
Repa JJ, Li H, Frank-Cannon TC, Valasek MA, Turley SD, Tansey MG, Dietschy JM
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007
Substrate reduction therapy of glycosphingolipid storage disorders
JM Aerts, CE Hollak, RG Boot, JE Groener, M Maas
Journal of Inherited Metabolic Disease 2006

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts